Severe Combined Immunodeficiency [clinicaltrials_resource:2776027bdeaf2d0efdb14d53c66d5cbe]
Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study [clinicaltrials:NCT00001255]Genetic Analysis of Immune Disorders [clinicaltrials:NCT00001467]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID [clinicaltrials:NCT00006335]Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant [clinicaltrials:NCT00008450]Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) [clinicaltrials:NCT00028236]Genetic Basis of Immunodeficiency [clinicaltrials:NCT00055172]Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome [clinicaltrials:NCT00152100]Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients [clinicaltrials:NCT00220766]IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency [clinicaltrials:NCT00228852]Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products [clinicaltrials:NCT00695279]clinicaltrials:NCT00794508Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population [clinicaltrials:NCT00845416]Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders [clinicaltrials:NCT00895271]clinicaltrials:NCT01019876clinicaltrials:NCT01129544clinicaltrials:NCT01182675EZN-2279 in Patients With ADA-SCID [clinicaltrials:NCT01420627]Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT01529827]Immune Disorder HSCT Protocol [clinicaltrials:NCT01821781]SCID Bu/Flu/ATG Study With T Cell Depletion [clinicaltrials:NCT02127892]clinicaltrials:NCT02177760Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China [clinicaltrials:NCT02231983]
condition [clinicaltrials_vocabulary:condition]
Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study [clinicaltrials:NCT00001255]Genetic Analysis of Immune Disorders [clinicaltrials:NCT00001467]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID [clinicaltrials:NCT00006335]Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant [clinicaltrials:NCT00008450]Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency [clinicaltrials:NCT00018018]Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) [clinicaltrials:NCT00028236]Genetic Basis of Immunodeficiency [clinicaltrials:NCT00055172]Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome [clinicaltrials:NCT00152100]Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients [clinicaltrials:NCT00220766]IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency [clinicaltrials:NCT00228852]clinicaltrials:NCT00490100clinicaltrials:NCT00579137Gene Therapy for ADA-SCID [clinicaltrials:NCT00599781]Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products [clinicaltrials:NCT00695279]clinicaltrials:NCT00794508Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population [clinicaltrials:NCT00845416]Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders [clinicaltrials:NCT00895271]clinicaltrials:NCT01019876clinicaltrials:NCT01129544Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1) [clinicaltrials:NCT01175239]clinicaltrials:NCT01182675Natural History Study of SCID Disorders [clinicaltrials:NCT01186913]Gene Therapy ADA Deficiency [clinicaltrials:NCT01279720]clinicaltrials:NCT01306019Patients Treated for SCID (1968-2010) [clinicaltrials:NCT01346150]Lentiviral Gene Therapy for Adenosine Deaminase (ADA) Deficiency [clinicaltrials:NCT01380990]clinicaltrials:NCT01410019EZN-2279 in Patients With ADA-SCID [clinicaltrials:NCT01420627]clinicaltrials:NCT01512888Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT01529827]Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [clinicaltrials:NCT01652092]Immune Disorder HSCT Protocol [clinicaltrials:NCT01821781]clinicaltrials:NCT01852071clinicaltrials:NCT01852370Participation in a Research Registry for Immune Disorders [clinicaltrials:NCT01953016]clinicaltrials:NCT02022696SCID Bu/Flu/ATG Study With T Cell Depletion [clinicaltrials:NCT02127892]clinicaltrials:NCT02177760
condition browse [clinicaltrials_vocabulary:condition-browse]
Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study [clinicaltrials:NCT00001255]Genetic Analysis of Immune Disorders [clinicaltrials:NCT00001467]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID [clinicaltrials:NCT00006335]Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant [clinicaltrials:NCT00008450]Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency [clinicaltrials:NCT00018018]Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) [clinicaltrials:NCT00028236]Genetic Basis of Immunodeficiency [clinicaltrials:NCT00055172]Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome [clinicaltrials:NCT00152100]Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients [clinicaltrials:NCT00220766]IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency [clinicaltrials:NCT00228852]clinicaltrials:NCT00490100clinicaltrials:NCT00579137Gene Therapy for ADA-SCID [clinicaltrials:NCT00599781]Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products [clinicaltrials:NCT00695279]clinicaltrials:NCT00794508Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population [clinicaltrials:NCT00845416]Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders [clinicaltrials:NCT00895271]clinicaltrials:NCT01019876clinicaltrials:NCT01129544Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1) [clinicaltrials:NCT01175239]clinicaltrials:NCT01182675Natural History Study of SCID Disorders [clinicaltrials:NCT01186913]Gene Therapy ADA Deficiency [clinicaltrials:NCT01279720]clinicaltrials:NCT01306019Patients Treated for SCID (1968-2010) [clinicaltrials:NCT01346150]Lentiviral Gene Therapy for Adenosine Deaminase (ADA) Deficiency [clinicaltrials:NCT01380990]clinicaltrials:NCT01410019EZN-2279 in Patients With ADA-SCID [clinicaltrials:NCT01420627]clinicaltrials:NCT01512888Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT01529827]Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [clinicaltrials:NCT01652092]Immune Disorder HSCT Protocol [clinicaltrials:NCT01821781]clinicaltrials:NCT01852071clinicaltrials:NCT01852370Participation in a Research Registry for Immune Disorders [clinicaltrials:NCT01953016]clinicaltrials:NCT02022696SCID Bu/Flu/ATG Study With T Cell Depletion [clinicaltrials:NCT02127892]clinicaltrials:NCT02177760
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Severe Combined Immunodeficiency [clinicaltrials_resource:2776027bdeaf2d0efdb14d53c66d5cbe]
Bio2RDF identifier
2776027bdeaf2d0efdb14d53c66d5cbe
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2776027bdeaf2d0efdb14d53c66d5cbe
identifier
clinicaltrials_resource:2776027bdeaf2d0efdb14d53c66d5cbe
title
Severe Combined Immunodeficiency
@en
type
label
Severe Combined Immunodeficien ...... 6027bdeaf2d0efdb14d53c66d5cbe]
@en
Severe Combined Immunodeficiency